Inventages Venture Capital Investment Inc.

Inventages Venture Capital Investment Inc is a venture capital firm and the investment arm of Nestle SA specializing in PIPES, seed, early, mid, and late ventures. Founded 2000 in London, England, United Kingdom by Gunnar Weikert, this venture capital firm invests in early and late stage ventures. Its portfolio companies include Accera, XOLUTION, Cognoptix, Inc., AM Pharma, Phagenesis, Phosphate Therapeutics, MSI Methylation Sciences, and Shield Therapeutics. As of February 2020, Inventages Venture Capital Investment Inc. has made 36 investments. Their most recent investment was on Oct 4, 2018, when Accera raised $50M. Inventages Venture Capital Investment Inc. has had 2 exits, the most notable of which include Shield Therapeutics and Phagenesis. The company has raised 7 funds, their latest being Inventages V. The firm seeks to invest in health care, life sciences, cosmeceuticals, pharmaceuticals, enabling technologies and services, and diagnostic and medical devices.